Literature DB >> 12154087

CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.

Md Kamrul Hasan1, Tomoko Yaguchi, Takashi Sugihara, Penmetcha K R Kumar, Kazunari Taira, Roger R Reddel, Sunil C Kaul, Renu Wadhwa.   

Abstract

The INK4a locus on chromosome 9p21 encodes two structurally distinct tumor suppressor proteins, p16(INK4a) and the alternative reading frame protein, ARF (p19(ARF) in mouse and p14(ARF) in human). Each of these proteins has a role in senescence of primary cells and activates pathways for cell cycle control and tumor suppression. The current prevailing model proposes that p19(ARF) activates p53 function by antagonizing its degradation by MDM2. It was, however, recently shown that stabilization of p53 by p14(ARF) occurs independent of the relocalization of MDM2 to the nucleolus. We have identified a novel collaborator of ARF, CARF. It co-localizes and interacts with ARF in the nucleolus. We demonstrate that CARF is co-regulated with ARF, cooperates with it in activating p53, and thus acts as a novel component of the ARF-p53-p21 pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12154087     DOI: 10.1074/jbc.M204177200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control.

Authors:  Md Kamrul Hasan; Tomoko Yaguchi; Yasumasu Minoda; Takashi Hirano; Kazunari Taira; Renu Wadhwa; Sunil C Kaul
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

2.  Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.

Authors:  Silvia S Borkosky; Mehmet Gunduz; Hitoshi Nagatsuka; Levent Bekir Beder; Esra Gunduz; Mahmoud A L Sheikh Ali; Andrea P Rodriguez; Mehmet Zeynel Cilek; Susumu Tominaga; Noboru Yamanaka; Kenji Shimizu; Noriyuki Nagai
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-08       Impact factor: 4.553

3.  Molecular characterization of apoptosis induced by CARF silencing in human cancer cells.

Authors:  C T Cheung; R Singh; A R Yoon; M K Hasan; T Yaguchi; S C Kaul; C O Yun; R Wadhwa
Journal:  Cell Death Differ       Date:  2010-11-05       Impact factor: 15.828

4.  A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2.

Authors:  Jialiang Wang; Xiaping He; Ying Luo; Wendell G Yarbrough
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

5.  Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.

Authors:  Chandrashekhar Korgaonkar; Jussara Hagen; Van Tompkins; April A Frazier; Chantal Allamargot; Frederick W Quelle; Dawn E Quelle
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

6.  Innate immune responses in NF-kappaB-repressing factor-deficient mice.

Authors:  Natali Froese; Michael Schwarzer; Ina Niedick; Ursula Frischmann; Mario Köster; Andrea Kröger; Peter P Mueller; Mahtab Nourbakhsh; Bastian Pasche; Jörg Reimann; Peter Staeheli; Hansjörg Hauser
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

7.  Strategic attack on host cell gene expression during adenovirus infection.

Authors:  Hongxing Zhao; Fredrik Granberg; Ludmila Elfineh; Ulf Pettersson; Catharina Svensson
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Stress-induced changes in CARF expression determine cell fate to death, survival, or malignant transformation.

Authors:  Rajkumar S Kalra; Anupama Chaudhary; Amr Omar; Caroline T Cheung; Sukant Garg; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2020-03-27       Impact factor: 3.667

Review 9.  Therapeutic targets in the ARF tumor suppressor pathway.

Authors:  Anthony J Saporita; Leonard B Maggi; Anthony J Apicelli; Jason D Weber
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  Collaborator of ARF (CARF) regulates proliferative fate of human cells by dose-dependent regulation of DNA damage signaling.

Authors:  Caroline T Cheung; Rumani Singh; Rajkumar S Kalra; Sunil C Kaul; Renu Wadhwa
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.